WHO's first guidance on paediatric dengue treatments is a significant step toward improving care for children affected by ...
GlobalData on MSN
FDA grants rare paediatric designation to Vanda’s CMT2S therapy
The status was granted by the FDA's Office of Orphan Products Development and Office of Pediatric Therapeutics.
Newsable Asianet News on MSN
VNDA Stock Gains After-Hours As FDA Grants Rare Pediatric Disease Designation For Experimental Therapy
The designation covers VCA-894A, Vanda’s investigational treatment for Charcot-Marie-Tooth disease type 2S.
A new study has found cannabidiol (medicinal cannabis) to be a promising treatment for several drug-resistant forms of ...
SHELTON, CT / ACCESS Newswire / June 29, 2026 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) ...
The year 2026 marked the 20th anniversary of the publication of the European Medicines Agency (EMA) reflection paper on ...
Incidence of medication problems and their harm potential following hospital discharge among pediatric patients with epilepsy were not significantly different for individuals who received discharge ...
In addition to healthy weight reduction through lifestyle changes, experts recommend anti-obesity medications and bariatric surgery to help manage metabolic dysfunction–associated steatotic liver ...
Whether children receive an opioid prescription after surgery varies substantially by procedure type and hospital, according ...
Please provide your email address to receive an email when new articles are posted on . From 2009 to 2020, emergency department visits for unsupervised pediatric medication exposures decreased by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results